Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2011/12/002219
CTRI/2011/12/002219
Completed
未知

A cross-sectional, observational study to assess proportion of primary hypothyroid patients having out-of-range serum TSH values despite being prescribed thyroxin and to probe reasons for the same - TISOT study

Abbott India Limited0 sites2,000 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Hypothyroidism

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Hypothyroidism
Sponsor
Abbott India Limited
Enrollment
2000
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients of either gender, aged more than or equal to 18 years and less than or equal to 60 years diagnosed with primary hypothyroidism.
  • •2\.Currently on treatment with any brand of levothyroxin for at least 3 months and on a stable dose of thyroxin for at least 2 months prior to enrolment.
  • •3\.Willing to provide written informed consent.

Exclusion Criteria

  • •1\.Patients receiving tri\-iodothyronine (T3\) as monotherapy or in combination with levothyroxin
  • •2\.Patients who are mentally retarded or unable to communicate
  • •3\.Patients with central hypothyroidism
  • •4\.Patients where hypothyroidism is likely to be transient
  • •5\.Pregnant and lactating women
  • •6\.Participating in any other clinical study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A study to evaluate oral and dental needs in treated head and neck cancer survivor participants
CTRI/2024/05/067984Advanced Center for Cancer Treatment Research and Education in Cancer ACTREC Tata Memorial Center
Completed
Not Applicable
Study to assess the prevalence of chronic kidney disease in Type 2 Diabetes.
CTRI/2015/05/005769AstraZeneca Pharma India Ltd3,000
Completed
Not Applicable
Study to assess the Prevalence of Heart Failure in Type 2 Diabetes Patients in IndiaHealth Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2019/08/020629AstraZeneca Pharma India Ltd621
Not yet recruiting
Not Applicable
Anti epileptic drugs and bone health - a cross sectional study of Indians with epilepsy
CTRI/2024/03/064935itte Universisty Grant
Not yet recruiting
Not Applicable
Comparison of Two Clinical Methods for Prediction of Difficult Airway for anaesthesiaHealth Condition 1: O- Medical and Surgical
CTRI/2024/05/067823KPC Medical College and Hospital